Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
Top Cited Papers
- 1 December 2011
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 261 (3), 834-844
- https://doi.org/10.1148/radiol.11101840
Abstract
Purpose To describe imaging findings of early hepatocellular carcinoma (HCC) at gadoxetic acid–enhanced magnetic resonance (MR) imaging, dynamic contrast material–enhanced computed tomography (CT), CT during arterial portography (CTAP), and CT during hepatic arteriography (CTHA) and to compare the diagnostic performance of each modality for small (≤2 cm) HCC. Materials and Methods The institute ethics committee deemed study approval unnecessary. One hundred eight resected small lesions in 64 patients were diagnosed as a dysplastic nodule (DN) (n = 12), progressed HCC (n = 66), or early HCC (n = 30). All but two patients underwent all imaging examinations. The imaging characteristics of the lesions with each modality were determined. To evaluate the diagnostic performance of the modalities, two radiologists graded the presence of HCC with use of a five-point confidence scale. The area under the receiver operating characteristic curve (Az), sensitivity, and specificity of each modality were compared. Results The imaging features that are statistically significant for differentiating an early HCC from a DN include fat-containing lesions at dual-echo T1-weighted MR imaging (seen in 16 of the 30 early HCCs and none of the DNs), low attenuation at unenhanced CT (seen in 13 of the 30 early HCCs and none of the DNs), low attenuation at CTAP (seen in 11 of the 30 early HCCs and none of the DNs), and low signal intensity at hepatocyte phase gadoxetic acid–enhanced MR imaging (seen in 29 of the 30 early HCCs and none of the DNs). The diagnostic performance of gadoxetic acid–enhanced MR imaging (Az, 0.98 and 0.99) was significantly greater than that of contrast-enhanced CT (Az, 0.87) and CTHA-CTAP (Az, 0.85 and 0.86) owing to its significantly higher sensitivity (P < .001). Conclusion Gadoxetic acid–enhanced MR imaging is the most useful imaging technique for evaluating small HCC, including early HCC. © RSNA, 2011This publication has 27 references indexed in Scilit:
- Detection and Characterization of Focal Liver LesionsInvestigative Radiology, 2010
- Additional Value of SPIO-Enhanced MR Imaging for the Noninvasive Imaging Diagnosis of Hepatocellular Carcinoma in Cirrhotic LiverInvestigative Radiology, 2009
- Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: Value of SPIO-enhanced MR imaging at 3.0 TeslaJournal of Magnetic Resonance Imaging, 2009
- Multistep human hepatocarcinogenesis: correlation of imaging with pathologyThe Esophagus, 2009
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasiaJournal of Hepatology, 2008
- East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinomaJournal of Hepatology, 2008
- The Value of Gadobenate Dimeglumine-Enhanced Delayed Phase MR Imaging for Characterization of Hepatocellular Nodules in the Cirrhotic LiverInvestigative Radiology, 2008
- Diagnostic discrepancy of early hepatocellular carcinoma between Japan and WestHepatology Research, 2007
- Terminology of nodular hepatocellular lesionsJournal of Hepatology, 1995